348 related articles for article (PubMed ID: 33862490)
21. Phages Needed against Resistant Bacteria.
Moelling K
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664292
[TBL] [Abstract][Full Text] [Related]
22. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
El-Shibiny A; El-Sahhar S
Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
[TBL] [Abstract][Full Text] [Related]
23. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
Kulshrestha M; Tiwari M; Tiwari V
Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
[TBL] [Abstract][Full Text] [Related]
24. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects.
Anyaegbunam NJ; Anekpo CC; Anyaegbunam ZKG; Doowuese Y; Chinaka CB; Odo OJ; Sharndama HC; Okeke OP; Mba IE
Microbiol Res; 2022 Nov; 264():127155. PubMed ID: 35969943
[TBL] [Abstract][Full Text] [Related]
25. [Possibilities of bacteriophage therapy].
Skurnik M; Kiljunen S
Duodecim; 2016; 132(8):712-9. PubMed ID: 27244930
[TBL] [Abstract][Full Text] [Related]
26. Engineering therapeutic phages for enhanced antibacterial efficacy.
Meile S; Du J; Dunne M; Kilcher S; Loessner MJ
Curr Opin Virol; 2022 Feb; 52():182-191. PubMed ID: 34952266
[TBL] [Abstract][Full Text] [Related]
27. [Phage therapy for respiratory infections].
Mitropoulou G; Gijs PJ; Koutsokera A; Sauty A; Blanchon S; Csajka C; Brunet JF; Resch G; Guery B; Von Garnier C
Rev Med Suisse; 2022 Nov; 18(804):2150-2156. PubMed ID: 36382975
[TBL] [Abstract][Full Text] [Related]
28. [Bacteriophages in the battle against multidrug resistant bacteria].
van der Meer JWM; Vandenbroucke-Grauls CMJE
Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
[TBL] [Abstract][Full Text] [Related]
29. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
Rohde C; Wittmann J; Kutter E
Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
[TBL] [Abstract][Full Text] [Related]
30. Phage therapy of wound-associated infections.
Zyman A; Górski A; Międzybrodzki R
Folia Microbiol (Praha); 2022 Apr; 67(2):193-201. PubMed ID: 35028881
[TBL] [Abstract][Full Text] [Related]
31. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
[TBL] [Abstract][Full Text] [Related]
32. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
[TBL] [Abstract][Full Text] [Related]
33. Bacteriophages and its applications: an overview.
Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
[TBL] [Abstract][Full Text] [Related]
34. Phages amid antimicrobial resistance.
Mohan Raj JR; Karunasagar I
Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
[TBL] [Abstract][Full Text] [Related]
35. Evolutionary Rationale for Phages as Complements of Antibiotics.
Torres-Barceló C; Hochberg ME
Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.
Uyttebroek S; Chen B; Onsea J; Ruythooren F; Debaveye Y; Devolder D; Spriet I; Depypere M; Wagemans J; Lavigne R; Pirnay JP; Merabishvili M; De Munter P; Peetermans WE; Dupont L; Van Gerven L; Metsemakers WJ
Lancet Infect Dis; 2022 Aug; 22(8):e208-e220. PubMed ID: 35248167
[TBL] [Abstract][Full Text] [Related]
37. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again.
Squires RA
N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297
[TBL] [Abstract][Full Text] [Related]
38. Phage therapy efficacy: a review of the last 10 years of preclinical studies.
Melo LDR; Oliveira H; Pires DP; Dabrowska K; Azeredo J
Crit Rev Microbiol; 2020 Feb; 46(1):78-99. PubMed ID: 32091280
[TBL] [Abstract][Full Text] [Related]
39. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
[TBL] [Abstract][Full Text] [Related]
40. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
